Authors
Loading...
Does not support clinical adoption of Hep G2 HDL subclasses; leaves open their in vivo relevance and metabolic roles.
Key points are not available for this paper at this time.
McCall et al. (1988) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: